The estimated Net Worth of David W Neu is at least 8.82 百万$ dollars as of 4 May 2015. David Neu owns over 62,971 units of Amerisource Bergen stock worth over 2,463,746$ and over the last 13 years David sold ABC stock worth over 6,359,061$.
David has made over 7 trades of the Amerisource Bergen stock since 2012, according to the Form 4 filled with the SEC. Most recently David exercised 62,971 units of ABC stock worth 2,244,916$ on 4 May 2015.
The largest trade David's ever made was exercising 62,971 units of Amerisource Bergen stock on 4 May 2015 worth over 2,244,916$. On average, David trades about 13,797 units every 53 days since 2012. As of 4 May 2015 David still owns at least 13,689 units of Amerisource Bergen stock.
You can see the complete history of David Neu stock trades at the bottom of the page.
David's mailing address filed with the SEC is 1300 MORRIS DRIVE, , CHESTERBROOK, PA, 19087.
Over the last 21 years, insiders at Amerisource Bergen have traded over 4,389,593,610$ worth of Amerisource Bergen stock and bought 18,610 units worth 1,659,872$ . The most active insiders traders include Boots Alliance, Inc.Walgree...、Lon R Greenberg、Steven H Collis. On average, Amerisource Bergen executives and independent directors trade stock every 14 days with the average trade being worth of 13,111,903$. The most recent stock trade was executed by Steven H Collis on 8 August 2023, trading 10,499 units of ABC stock currently worth 813,987$.
amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.
Amerisource Bergen executives and other stock owners filed with the SEC include: